Clinical remission and response in patients with Crohn´s disease treated open-label for 6-months with fully human anti-TNF monoclonal antibody adalimumab | Charles Explorer

Clinical remission and response in patients with Crohn´s disease treated open-label for 6-months with fully human anti-TNF monoclonal antibody adalimumab

Publication

Abstract

Crohn´s disease

People